NuScale 10-Qquarter ended 2026-06-30

Executive Summary

NuScale Power is funding commercialization of its approved 77 MWe nuclear module design, but Q2 delivered almost no revenue as earlier engineering work ended and prospective plant projects remained short of binding equipment orders. Operating losses widened, while H1 operating cash use was amplified by settlement of a partnership milestone expense recognized in 2025. A $984M net stock sale left NuScale with substantial liquidity and no debt, but increased shares outstanding by 29%. The investment case now rests on converting ENTRA1 and Romanian project progress into financed contracts before continued development spending consumes that cushion.

Key Financial Highlights

• Revenue mix: Power Plant and module-related services produced negative Q2 revenue of $(0.175)M after the Fluor adjustment; Energy Exploration Center revenue of $0.250M accounted for the quarter’s positive revenue.
• Spending: H1 research and development rose to $31.2M from $20.9M, while general and administrative expense reached $51.7M and other expenses $38.4M. Fewer customer projects absorbed project-personnel costs as NuScale invested in component and supply-chain readiness.
• Cash conversion: H1 operating cash use rose from $56.1M a year earlier; the principal driver was a $260M ENTRA1 milestone payment, expensed in 2025. That payment makes current cash use materially worse than the current-period loss without indicating a newly recognized H1 expense.
• Funding and dilution: H1 issuance of 89.7M shares raised $984M net; Class A shares outstanding increased from 318M to 410M. H1 stock-based compensation was $11.8M.
• Liquidity: Cash and cash equivalents were $766M, with $306M of short-term and $821M of longer-term investments. Investment income reached $13.9M in Q2 and $24.8M in H1, cushioning losses but not replacing commercial revenue.

Business Developments

NuScale’s May 2025 regulatory approval permits customers to reference its 77 MWe module design in U.S. licensing applications; it does not itself secure construction or equipment sales. Management is directing resources toward design maturity and supply-chain readiness, including $25.8M of Paragon contracts signed in July.

ENTRA1 is NuScale’s exclusive global commercialization and plant-development partner, but retains discretion over project selection and purchases. Its nonbinding collaboration with Tennessee Valley Authority contemplates up to 6 GW of generation; deployment using NuScale equipment depends on future power-purchase agreements. A separate nonbinding 72-module arrangement triggered a $507M expense in 2025, fully settled by H1 2026, demonstrating that partnership commitments can precede equipment revenue.

Romania approved an investment decision for the Doicești project in February, allowing further development—not construction. RoPower must secure financing before an anticipated pre-construction contract phase. Completion of its earlier engineering phase explains much of the revenue decline; financing and contracting, rather than design approval alone, are the next commercial tests.

Risk Assessment

• Commercial conversion: Revenue fell to $0.075M in Q2 while proposed ENTRA1 projects remain nonbinding, leaving losses dependent on converting development activity into equipment orders.
• Partner dependence: ENTRA1 controls whether to pursue opportunities, and NuScale generally needs its consent to pursue them independently; this concentrates commercialization decisions outside NuScale.
• Cash consumption and dilution: H1 operating cash use was $373M; although liquidity is substantial, sustained spending without contracts could require further shareholder dilution.
• Project financing and timing: RoPower is not expected to enter its next contract phase until it secures financing, delaying potential revenue despite Romania’s investment decision.
• Commitments: Disclosed obligations and commitments total $168M, including $52.2M for sales and marketing; spending can precede customer orders.
• Litigation: A securities class action concerning statements about ENTRA1’s capabilities seeks unspecified damages; NuScale cannot estimate a potential loss.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: FY2025 10-K.

Strategic Outlook and Investor Actionables

NuScale has an approved design and the capital to advance projects, but the near-term thesis is execution, not current earnings. Investors should distinguish project announcements from financed agreements that produce recurring revenue.

• Contract conversion: Watch for binding ENTRA1-linked equipment orders or power-purchase agreements; continued nonbinding announcements would leave the revenue thesis unproven.
• Romania: Watch for RoPower financing and a pre-construction contract; further development work without those milestones would extend the revenue gap.
• Cash and dilution: Compare next-period operating cash use with the H1 figure after the settled ENTRA1 payment, alongside shares outstanding; persistent high cash use or renewed issuance would weaken the funding thesis.